Skin sensitization testing in potency and risk assessment

Area of Science:

• Toxicology
• Dermatology
• Risk Assessment

Background:

• Skin sensitization is a significant health concern.
• Accurate assessment of chemical allergen potency is crucial for risk management.
• Existing methods for evaluating skin sensitization vary in their reliability and applicability.

Purpose of the Study:

• To review and recommend skin sensitization test methods for determining relative potency and threshold doses.
• To evaluate the utility of various animal and human tests for potency assessment and risk analysis.
• To provide guidance on selecting appropriate methods for regulatory and safety evaluations.

Main Methods:

• Comparative review of guinea pig tests (maximization, occluded patch, open epicutaneous).
• Evaluation of the Local Lymph Node Assay (LLNA) and its EC3 value derivation.
• Consideration of human volunteer testing (Human Repeat Insult Patch Test).

Main Results:

• Guinea pig maximization test is generally unsuitable for relative potency determination.
• Adjuvant-free guinea pig tests (occluded patch, open epicutaneous) are more appropriate for relative potency.
• The LLNA provides a quantitative basis (EC3 values) for assessing relative skin sensitizing potency.
• Human testing is valuable for confirming product safety under specific exposure conditions.

Conclusions:

• The LLNA is the recommended method for new potency assessments and formulation influence studies.
• Existing guinea pig data can be valuable if interpreted judiciously.
• Human sensitization data should be integrated into potency assessments and risk evaluations.
• All available animal and human data are essential for comprehensive risk assessment.